Building World Class Life Science Businesses – The Good, The Bad and The Ugly

Jonathan Milner, co-founder of Abcam, offers a masterclass in building successful life science starts-ups, based on his experience with over 40 companies and three Tech IPOs on the London AIM Stock Exchange.

  • Mon 22nd Jan 2018

Jonathan will be looking at the bigger picture trends and breakthroughs in life sciences and then explain how he is trying to translate this exciting science into businesses. His particular areas of interest include stem cell technology; new approaches to drug discovery; genomics and proteomics big data; and diseases of ageing and the ageing process.

Jonathan cofounded Abcam when working as a postdoctoral researcher studying the newly discovered breast cancer protein BRCA2 in Kouzarides' Cambridge University laboratory. Now a listed e-commerce company providing antibodies and other protein research tools to a global market, it encourages and publishes product reviews and ratings submitted by customers.

Horizon Discovery designs and engineers genetically modified cells, applying them in research and clinical applications that advance human health.

Dr. Jonathan Milner, Deputy Chairman, Abcam plc

Attending lectures

Full video

Audience feedback

The lecture will be preceded by a short presentation from a CSAR PhD Student Award winner

Stabilising Omomyc - a new cancer drug

Sarah Madden

Full video